Armitage, J.D., Newnes, H.V., McDonnell, A., Bosco, A. and Waithman, J. 2021. Fine-tuning the tumour microenvironment: Current perspectives on the mechanisms of tumour immunosuppression. Cells, 10(1): 56.
Blaise, G.A., Gauvin, D., Gangal, M. and Authier, S. 2005. Nitric oxide, cell signaling and cell death. Toxicology, 208(2): 177-192.
Boulanger, N. 2018. Skin and arthropod vectors. Academic Press.
Cakir, B.Ö., Adamson, P. and Cingi, C. 2012. Epidemiology and economic burden of nonmelanoma skin cancer. Facial plastic surgery clinics of North America, 20(4): 419-422.
Chill, H., Safrai, M., Reuveni Salzman, A. and Shushan, A. 2017. The rising phoenix-progesterone as the main target of the medical therapy for leiomyoma. BioMed research international, 2017.
Choudhari, S.K., Chaudhary, M., Bagde, S., Gadbail, A.R. and Joshi, V. 2013. Nitric oxide and cancer: A review. World journal of surgical oncology, 11(1): 1-11.
Delker, S.L., Xue, F., Li, H., Jamal, J., Silverman, R.B. and Poulos, T.L. 2010. Role of zinc in isoform-selective inhibitor binding to neuronal nitric oxide synthase. Biochemistry, 49(51): 10803-10810.
Dimitrakakis, C., Zava, D., Marinopoulos, S., Tsigginou, A., Antsaklis, A. and Glaser, R. 2010. Low salivary testosterone levels in patients with breast cancer. BMC cancer, 10(1): 1-8.
Funder, J.W., Krozowski, Z., Myles, K., Sato, A., Sheppard, K.E. and Young, M. 1997. Mineralocorticoid receptors, salt, and hypertension. Recent progress in hormone research, 52: 247-260; discussion 261.
Heijmans, J., Muncan, V., Jacobs, R.J., de Jonge-Muller, E.S., Graven, L., Biemond, I., Ederveen, A.G., Groothuis, P.G., Mosselman, S. and Hardwick, J.C. 2011. Intestinal tumorigenesis is not affected by progesterone signaling in rodent models. PLoS One, 6(7): e22620.
Khorram, O. and Han, G. 2009. Influence of progesterone on endometrial nitric oxide synthase expression. Fertility and sterility, 91(5): 2157-2162.
Kolovou, G., Ragia, G., Kolovou, V., Mihas, C., Katsiki, N., Vasiliadis, I., Mavrogeni, S., Vartela, V., Tavridou, A. and Manolopoulos, V.G. 2014. Impact of cyp3a5 gene polymorphism on efficacy of simvastatin. The open cardiovascular medicine journal, 8: 12.
Li, X. and O'Malley, B.W. 2003. Unfolding the action of progesterone receptors. Journal of biological chemistry, 278(41): 39261-39264.
Liu, Y. and Feng, Q. 2012. Noing the heart: Role of nitric oxide synthase-3 in heart development. Differentiation, 84(1): 54-61.
Meier, P., Finch, A. and Evan, G. 2000. Apoptosis in development. Nature, 407(6805): 796-801.
Mohsenpour, K., Hekmat, A., Atyabi, S.M. and Bakhshandeh, H. 2021. Nanoscale, 8(1): 132-148.
Richards, G., Klimek, M., Jasienska, G. and Marcinkowska, U.M. 2018. Digit ratio (2d: 4d) and circulating testosterone, oestradiol, and progesterone levels across the menstrual cycle. Early human development, 117: 68-73.
Schini-Kerth, V.B., Auger, C., Kim, J.-H., Étienne-Selloum, N. and Chataigneau, T. 2010. Nutritional improvement of the endothelial control of vascular tone by polyphenols: Role of no and edhf. Pflügers Archiv-European Journal of Physiology, 459(6): 853-862.
Shutze, W.P. and Patman, R.D. 1995. Nonatherosclerotic vascular diseases and vasospastic conditions: Inflammatory conditions (part 1 of a 3-part series). In: Baylor University Medical Center Proceedings. Taylor & Francis: pp: 21-28.
Sudhakar, A. 2009. History of cancer, ancient and modern treatment methods. Journal of cancer science & therapy, 1(2): 1.
Taguchi, K., Morishige, A., Matsumoto, T., Kamata, K. and Kobayashi, T. 2012. Enhanced estradiol-induced vasorelaxation in aortas from type 2 diabetic mice may reflect a compensatory role of p38 mapk-mediated enos activation. Pflügers Archiv-European Journal of Physiology, 464(2): 205-215.
Verzola, D., Gandolfo, M.T., Salvatore, F., Villaggio, B., Gianiorio, F., Traverso, P., Deferrari, G. and Garibotto, G. 2004. Testosterone promotes apoptotic damage in human renal tubular cells. Kidney international, 65: 252–1261.
)